Lahanya Guha

About

A motivated doctoral research Scholar from NIPER AHMEDABAD. with the desire to learn new skills and move out of my comfort zone with a scientific and rational approach. Has experience of managing multiple educational tasks at the same time with commitment towards quality. Proficient in Animal Modeling,Neuroscience ,Nanotechnology, Pharmacology etc. Empathic listener and an articulate speaker

Employment

• Haldia Institute of Technology Assistant Professor
  2026 - Present
• Yenepoya University Research Associate
  2026 - 2026

Education

• National Institute of Pharmaceutical Education and Research PhD
  2021 - Present
• National Institute of Pharmaceutical Education and Research M. S Pharm
  2019 - 2021
• NSHM Knowledge Campus - Kolkata B. Pharm
  2015 - 2019
• Krishnagar Collegiate School Science
  2012 - 2014
• Krishnagar Debnath High School Secondary
  2002 - 2012

Projects & Funding

Projects & funding information is unavailable.

Publications (16)

• Disruption of cellular timekeeping in cancer: links between circadian clocks, metabolism, and tumor progression
  Molecular Biology Reports 2026 DOI: 10.1007/s11033-026-12675-0
  +Save
• Spastic and non-spastic spinal cord injury induce systemic reproductive impairment via alterations in testicular morphology, microenvironment, spermatogenesis, and modulation of sperm parameters
  The Journal of Spinal Cord Medicine 2026 DOI: 10.1080/10790268.2026.2709255
  +Save
• Living drug carriers: Microbial and bioengineered platforms redefining precision therapeutic and immunomodulatory delivery
  Journal of Controlled Release 2026 DOI: 10.1016/j.jconrel.2026.115274
  +Save
• Exosome-based nanomedicine for neurological disorders: mechanisms, engineering, and therapeutic potential
  Therapeutic Delivery 2026 DOI: 10.1080/20415990.2026.2715878
  +Save
• Nano-shields: Exploring the role of antioxidant mimicking nanoparticles as regenerative therapy in spinal cord injury
  Biomaterials Advances 2026 DOI: 10.1016/j.bioadv.2025.214484
  +Save
• Pyruvate kinase M2 – linked metabolic pathways in pain modulation
  Drug Discovery Today 2026 DOI: 10.1016/j.drudis.2025.104557
  +Save
• Phenserine Mitigates Neuroinflammation, Apoptosis, and Behavioural Deficits to Enhance Motor Function and Recovery in a Mouse Model of Spinal Cord Injury
  Molecular Neurobiology 2025 DOI: 10.1007/s12035-025-05166-z
  +Save
• Evaluating the Role of Lin-11, Isl-1, and Mec-3 Kinases in Dopaminergic Neurodegeneration in a Subacute 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Model of Parkinson’s Disease
  ACS Pharmacology & Translational Science 2024 DOI: 10.1021/acsptsci.4c00423
  +Save
• Challenges in Drug Development for Neurological Disorders
  Drug Delivery Strategies in Neurological Disorders: Challenges and Opportunities 2024 DOI: 10.1007/978-981-99-6807-7_2
  +Save
• From hope to healing: Exploring the therapeutic potential of exosomes in spinal cord injury
  Extracellular Vesicle 2024 DOI: 10.1016/j.vesic.2024.100044
  +Save